15:43Ivo Rausch, Vienna / AT
1. To understand image distortions, artefacts, and bias from methodological pitfalls in PET/CT and PET/MR imaging.
2. To learn about possible solutions to frequent image distortions.
3. To understand the methodological limitations of PET/CT and PET/MRI.
18:09Jose Luis Vercher-Conejero, Barcelona / ES
1. To become familiar with the different types of pitfalls in FDG-PET/CT imaging and how to minimise them.
2. To understand the strengths and limitations of FDG-PET/CT as a hybrid imaging modality.
3. To learn about the correct patient preparation, relevant patient history, and data and study acquisition.
14:01Clemens C. Cyran, Munich / DE
1. To learn about the most frequent pitfalls and artefacts of PET tracers beyond FDG.
2. To appreciate the most important risks of misinterpretation with PET tracers beyond FDG.
3. To understand the physiological background of pitfalls and artefacts when imaging with PET tracers beyond FDG.
Center for Medical Physics and Biomedical Engineering, Medical University Vienna
Dr José L Vercher-Conejero is a nuclear medicine physician in the Department of Nuclear Medicine/PET Unit at the University Hospital of Bellvitge (Barcelona, Spain). During his training period, for his merits he was awarded a scholarship by the Official College of Physicians of Valencia and invited by the Mount Sinai Medical Hospital of New York to perform a rotation in the Department of Radiology. He has been working at the University and Polytechnic Hospital La Fe in Valencia (Department of Nuclear Medicine – Clinical Area of Medical Imaging), being also a member of the “Biomedical and Imaging Research Group – (GIBI230)”, and carried out a fellowship in the Department of Radiology at UH Hospital/Case Western Reserve University in Cleveland (Ohio, USA), specializing in PET/MRI and digital PET mainly. His interests are in oncological PET/CT, PET/MR, SPECT/CT, FDG and Non-FDG radiopharmaceuticals, and radiometabolic therapy (PRRT for NETs, endocrine disorders and endocrine oncology, treatment of bone metastases, microspheres with Y-90 for the treatment of intrahepatic tumour lesions, among others). From March 2019, Dr Vercher-Conejero is the Hybrid Imaging Ambassador for Spain for the European Society for Hybrid, Molecular and Translational Imaging (ESHIMT).
Department of Radiology, Laboratory of Experimental Radiology, University Hospitals Munich